Get Premium

Get Premium

Dominate Financial Markets with Stock Target Advisor Premium Features

Discover
Discover

Explore new stock opportunities and market trends for better investment decisions.
- Analyst Ratings & Stock Picks
- Top Stocks
- Latest Analyst Ratings
- Analyst Directory
- Worst Stocks
- Sector Ratings & Performance
- Smart Filters
- Best Penny Stocks
- Best Dividend Stocks
- Best Crypto Stocks
- Best Performing Stocks
- Worst Performing Stocks
- Highest Income ETFs
Research
Research

Access in-depth stock analysis and expert evaluations to guide your investments
- Automatic Selection
- Stocks/ETF Screener
- Query Builder
- Analyst Screener
- Automated Research Reports
- Best Stocks Filters
- Thematic Stock Screens
- Sector Stock Screens
Learn
Learn

Utilize our extensive educational resources designed to enhance your investing knowledge and skills
- Market News & Insights
- Stock Target Advisor Insights
- Tutorials
- Market News
- Stock Calendars
- Earnings Calendar
- IPO Calendar
- Splits Calendar
Watchlists & Portfolios
Watchlists & Portfolios

Easily manage, track, and optimize your stock selections for maximum returns
Engage
Engage

Connect with the investing community and access free widgets for better stock insights

The Improved Experience You’ve Been Waiting For! Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach. Explore Now

BLACR Bellevue Life Sciences Acquisition Corp. Rights

Current Price USD 0.11 0.00 ( 0)

Bellevue Life Sciences Acquisition Corp. Rights (BLACR) Stock Analysis and Price Targets

COMMON STOCK | | NSD

Target Add to Watchlist

Take a Tour

N/A

Average Analyst
Rating

Neutral

Stock Target Advisor
Analysis

N/A

Average User
Rating

Last Closing Price

USD 0.11

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.10M

Avg User Target

N/A

BLACR

Bellevue Life Sciences Acquisition Corp. Rights (USD)

COMMON STOCK | NSD

USD 0.11

0.00 ( 0)

Watchlist

Bellevue Life Sciences Acquisition Corp. Rights (BLACR) Annual Income Statement (USD)

BLACR Quarterly Financials (USD)

Frequently Asked Questions About Bellevue Life Sciences Acquisition Corp. Rights (BLACR) Stock

Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) last reported annual revenue was N/A.

Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

Bellevue Life Sciences Acquisition Corp. Rights's(BLACR) is not profitable as of its last reported annual financials.

The net profit margin for Bellevue Life Sciences Acquisition Corp. Rights's(BLACR) from its laster reported year is N/A

The return on equity (ROE) for Bellevue Life Sciences Acquisition Corp. Rights's(BLACR) from its last reported annual financials is : 0.00%

The return on assets (ROA) for Bellevue Life Sciences Acquisition Corp. Rights's(BLACR) from its last reported annual financials is : 0.00%

The return on invested capital (ROIC) for Bellevue Life Sciences Acquisition Corp. Rights's(BLACR) from its last reported annual financials is : 0.00%

The Debt to Equity ratio for Bellevue Life Sciences Acquisition Corp. Rights's(BLACR) from its last reported annual financials is : 0.00%

The dividend yield for Bellevue Life Sciences Acquisition Corp. Rights's(BLACR) from its laster reported year is 0.00%

Bellevue Life Sciences Acquisition Corp. Rights's(BLACR) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like

There is nothing we particularly like

What not to like

There is nothing we particularly dislike

Symbol: BLACR:NSD

What is your target rating?*

Sell

Hold

Buy

What is your target price?*

USD

What is your Time Horizon for the Target Price ( between 0 - 11 months) ?*

- +

Share your analysis

1000 characters left

Get our Premium Service free for 7-days!

Link watchlist to your brokerage
Premium Newsletter
Daily Analyst Ratings
Detailed Stock Analysis
Top Picks
Watchlists and Portfolios
Advanced Screens
Detailed Reports
Donwloadable Data

Join over half-million smart investors across the world

Select Market

I agree to Stock Target Adivsor Terms and Conditions

or Sign up with

Bellevue Life Sciences Acquisition Corp. Rights (BLACR) Stock Analysis and Price Targets

User Analysis

User Analysis

Bellevue Life Sciences Acquisition Corp. Rights (BLACR) Annual Income Statement (USD)

BLACR Quarterly Financials (USD)

Frequently Asked Questions About Bellevue Life Sciences Acquisition Corp. Rights (BLACR) Stock

What is Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) annual revenue?

What is Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) annual revenue growth rate?

Is Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) profitable?

What is Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) net profit margin?

What is Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) return on equity?

What is Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) return on Assets?

What is Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) return on Invested Capital?

What is Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) debt-to-equity ratio?

What is Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) dividend yield?

Does Bellevue Life Sciences Acquisition Corp. Rights's (BLACR) have a positive cash flow ?

Stock Target Advisor's Analysis

What to like

There is nothing we particularly like

What not to like

There is nothing we particularly dislike